In a drug discovery career spanning more than two decades, Alex Lugovskoy has seen a lot of antibodies come and go. The vast majority of them work by inhibiting a cellular function. Lugovskoy, now the ...

Backed by more than a dozen prominent investors, the startup is advancing into human testing a drug it believes capable of treating two disparate conditions, one of which is the target of Merck’s fast ...

This is part of the How Football Works series, a piece-by-piece look at the mechanics of the game If you’re a football team who would like to get the ball past the other team and into the net, you ...

Over the last decade, officials have tried a series of steps to rein in cars on Los Angeles streets. They turned parking spaces into micro-parks, converted street corners into trendy plazas and ...

Alex Lugovskoy, PhD, an author of over 100 patents and an expert in antibody R&D, is working hard to unlock one of the most important areas of drug discovery and development: agonist antibodies for ...